Peter brings over 25 years of experience building and leading Clinical Operations teams across biopharmaceutical sponsors, guiding programs from first-in-human studies through pivotal trials and global approvals in oncology and rare diseases. A cancer survivor, he brings personal passion to advancing therapies for underserved patient populations and is committed to improving the clinical trial experience for patients of all ages. Recognized as a 2020 Emerging Pharma Leader by Pharmaceutical Executive, Peter is known for operational excellence and innovative approaches to sponsor and vendor partnerships.
Archives: Speakers
Anurag Chitlangia
Jonas Persson
Richard Göransson
Nicola Rhone
Nicola Rhone is VP Business Development EMEA at Access Hospitality, where she leads strategy and growth across the accommodation portfolio. With deep experience in hospitality technology, Nicola works closely with hoteliers to help them optimise performance, improve guest engagement, and navigate an increasingly digital and data-driven landscape. She is a trusted industry voice on innovation, revenue optimisation, and the future of hotel technology.
Alex Dinsdale
Richard Rosenberg
Joe Buck
Joe Buck is a Senior Operations Engineer at ThreatSpike, specialising in endpoint security deployment and client implementation. With five years of defensive cybersecurity experience, Joe works directly with clients to deploy monitoring solutions, implement security controls, and provide strategic guidance tailored to their operational needs. He has developed deep expertise in endpoint hardening, with a particular focus on balancing robust security with operational continuity, ensuring defences strengthen without disrupting business performance or usability.
email: Joe.Buck@ThreatSpike.com
Nyah Phengsitthy
Nyah Phengsitthy is a reporter for Bloomberg Law covering the FDA’s oversight of the tobacco and pharmaceutical industry. She closely tracks and writes about regulations, litigation, and policies impacting those industries. She’s a frequent guest on TV and radio, health podcasts, and panels discussing the government’s health care actions. Before joining Bloomberg, she wrote about the impact of COVID-19 on orphanages in Ghana for the Pulitzer Center on Crisis Reporting. She’s a graduate of Elon University.
Teresa Ferreiro
Teresa Ferreiro-Vilariño is a certified professional coach, business facilitator, and patient advocate with over 20 years of experience working with leaders, organizations, and individuals navigating complex transitions.
At the age of 36, a breast cancer diagnosis redirected her professional focus toward empowering people living with cancer to reclaim agency, voice, and choice in the midst of illness. What began as a personal turning point became a professional calling.
In 2012, she authored the award-winning book I Have Breast Cancer – What Now?, offering guidance and hope to thousands of readers. Two years later, she founded Baby Beatles, a charity supporting women who wish to become mothers after breast cancer. In recognition of her commitment to patient advocacy, she received the European Patient Champion Award in 2019.
In 2022, Teresa earned her Ph.D., with research centered on applying professional coaching methodologies to strengthen patient empowerment and resilience.
She is now preparing to publish her forthcoming book, Navigate Cancer – Coaching for Resilience, a transformative guide designed to reshape how we approach cancer—moving beyond the purely medical lens to foster self-leadership, resilience, and purposeful living for those affected by the disease.
Teresa is the founder of Kimberlite (www.kimberlite.es), where she offers specialized coaching and personal development programs for individuals living with cancer, as well as workshops and leadership development initiatives within organizations. She also serves as a leadership coach at IMD Business School, working with senior executives and global leaders.